Abstract 3791: A prognostic signature based on inherited genetic polymorphisms for patients with uveal melanoma

黑色素瘤 医学 癌症 签名(拓扑) 肿瘤科 内科学 癌症研究 几何学 数学
作者
Thibault Verrier,Anne L. van de Ven,Alexandre Houy,Agathe Garcia,Gaëlle Pierron,Nathalie Cassoux,Manuel Rodrigues,Josselin Noirel,Marc‐Henri Stern
出处
期刊:Cancer Research [American Association for Cancer Research]
卷期号:84 (6_Supplement): 3791-3791
标识
DOI:10.1158/1538-7445.am2024-3791
摘要

Abstract Introduction: Uveal melanoma (UM) is the most frequent eye malignancy in adults. Two UM subtypes exist, defined by Gene Expression Profiling or by genomic status: GEP class 1/disomy 3 [D3] and GEP class 2/monosomy 3 [M3] defining low-risk or high-risk of developing metastasis, respectively. However, these prognostic signatures require tumor samples, which may be difficult to obtain. We previously identified by a genome-wide association study (GWAS) frequent single nucleotide polymorphisms (SNP) in IRF4 and HERC2 associated with risk for D3 or M3 UM, respectively (1). Here, we aim to design a prognostic signature for the D3 and M3 UM subtypes based on these constitutive polymorphisms, available from blood samples. Experimental Procedures: We used the GWAS cohort of 1476 UM patients genotyped on GSA or Omni5. Risk SNPs coupled with clinical variables were used on a cohort of 497 UM patients (191 D3, 306 M3) in a statistical machine learning process to define a predictive signature of UM subtype. A cohort of 852 UM patients was used for validation. Results: We retained two SNPs, rs12203592 (in IRF4) and rs12913832 (in HERC2), tumor diameter and thickness, age at diagnosis and gender. We validated the predictive model in the validation cohort. The predicted high-risk group showed a decrease in time to relapse (TR) (HR: 3.72 [2.57 - 5.41], logrank p-value = 1.35E-15), overall survival (OS) (HR: 3.85 [2.58 - 5.73], logrank p-value = 1.24E-14) and progression-free-survival (PFS) (HR: 3.61 [2.32 - 5.61], logrank p-value = 6.55E-11), compared with the predicted low-risk group. Conclusion: Common germline polymorphisms contribute to the prediction of metastatic risk in patients with localized uveal melanoma. This information could be especially useful when access to the tumor is problematic. 1. Mobuchon et al, J Natl Cancer Inst, 114, 2, (2022) Citation Format: Thibault Verrier, Anaïs Le Ven, Alexandre Houy, Agathe Garcia, Pierron Gaelle, Nathalie Cassoux, Manuel Rodrigues, Josselin Noirel, Marc-Henri Stern. A prognostic signature based on inherited genetic polymorphisms for patients with uveal melanoma [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2024; Part 1 (Regular Abstracts); 2024 Apr 5-10; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2024;84(6_Suppl):Abstract nr 3791.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
Herman_Chen完成签到,获得积分10
1秒前
Zn应助牛文文采纳,获得10
3秒前
3秒前
4秒前
贤惠的白开水完成签到 ,获得积分10
4秒前
英姑应助林林林采纳,获得10
5秒前
科研小民工应助Anquan采纳,获得30
5秒前
cyt9999发布了新的文献求助10
6秒前
天天快乐应助好难啊采纳,获得10
7秒前
干净的烧鹅完成签到,获得积分10
8秒前
9秒前
9秒前
在人中发布了新的文献求助10
10秒前
10秒前
fls221完成签到,获得积分10
11秒前
Laity完成签到,获得积分10
13秒前
13秒前
健忘捕发布了新的文献求助10
13秒前
林林林发布了新的文献求助10
14秒前
ok完成签到 ,获得积分10
15秒前
乐乐应助wewe采纳,获得30
15秒前
15秒前
拥有八根情丝完成签到 ,获得积分10
16秒前
科研通AI5应助Rex采纳,获得10
17秒前
18秒前
情怀应助樱桃小丸子采纳,获得10
19秒前
好难啊发布了新的文献求助10
20秒前
20秒前
24秒前
25秒前
25秒前
wewe完成签到,获得积分20
26秒前
李大爷发布了新的文献求助10
26秒前
Kevin完成签到,获得积分10
28秒前
酷炫的尔丝完成签到 ,获得积分10
28秒前
Hello应助标致的蛋挞采纳,获得50
29秒前
大个应助明亮的宁采纳,获得10
30秒前
Rainbow发布了新的文献求助10
30秒前
anyone发布了新的文献求助30
31秒前
充电宝应助SY采纳,获得10
32秒前
高分求助中
Continuum Thermodynamics and Material Modelling 3000
Production Logging: Theoretical and Interpretive Elements 2700
Ensartinib (Ensacove) for Non-Small Cell Lung Cancer 1000
Unseen Mendieta: The Unpublished Works of Ana Mendieta 1000
Bacterial collagenases and their clinical applications 800
El viaje de una vida: Memorias de María Lecea 800
Luis Lacasa - Sobre esto y aquello 700
热门求助领域 (近24小时)
化学 材料科学 生物 医学 工程类 有机化学 生物化学 物理 纳米技术 计算机科学 内科学 化学工程 复合材料 基因 遗传学 物理化学 催化作用 量子力学 光电子学 冶金
热门帖子
关注 科研通微信公众号,转发送积分 3528035
求助须知:如何正确求助?哪些是违规求助? 3108306
关于积分的说明 9288252
捐赠科研通 2805909
什么是DOI,文献DOI怎么找? 1540220
邀请新用户注册赠送积分活动 716950
科研通“疑难数据库(出版商)”最低求助积分说明 709851